Silo Pharma, Inc. (NASDAQ:SILO) Short Interest Down 68.1% in May

Silo Pharma, Inc. (NASDAQ:SILOGet Free Report) was the target of a large decline in short interest in the month of May. As of May 31st, there was short interest totalling 34,200 shares, a decline of 68.1% from the May 15th total of 107,200 shares. Approximately 1.0% of the shares of the company are sold short. Based on an average daily volume of 242,600 shares, the days-to-cover ratio is currently 0.1 days.

Silo Pharma Stock Down 9.1 %

SILO stock traded down $0.11 during trading hours on Friday, hitting $1.10. 202,817 shares of the stock were exchanged, compared to its average volume of 191,946. Silo Pharma has a 12 month low of $1.05 and a 12 month high of $3.05. The company has a 50-day simple moving average of $1.83 and a two-hundred day simple moving average of $1.67.

Silo Pharma (NASDAQ:SILOGet Free Report) last released its quarterly earnings results on Monday, May 13th. The company reported ($0.28) EPS for the quarter. Silo Pharma had a negative return on equity of 51.75% and a negative net margin of 4,992.30%. The business had revenue of $0.02 million for the quarter.

Silo Pharma Company Profile

(Get Free Report)

Silo Pharma. Inc, a developmental stage biopharmaceutical company, develops traditional therapeutics and psychedelic medicine. Its lead program includes SPC-15, an intranasal drug targeting post-traumatic stress disorder (PTSD) and stress-induced anxiety disorders; and SP-26, a ketamine-based loaded implant indicated for fibromyalgia and chronic pain relief.

Featured Articles

Receive News & Ratings for Silo Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silo Pharma and related companies with MarketBeat.com's FREE daily email newsletter.